Methods for treating dermatitis using mutant human IL-4 compositions

Details for Australian Patent Application No. 2006261335 (hide)

Owner Bayer Pharmaceuticals Corporation

Inventors Fuller, Richard

Agent Freehills

Pub. Number AU-A-2006261335

PCT Pub. Number WO2006/138668

Priority 11/156,221 17.06.05 US

Filing date 16 June 2006

Wipo publication date 28 December 2006

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2006/138668 Priority application(s): WO2006/138668

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006261342-Her-2 peptides

2006261327-Sphingosine kinase inhibitors